L’Oreal Sues Competitors J&J, Merck For Sunscreen Patent Infringement
This article was originally published in The Rose Sheet
Executive Summary
L’Oreal says competitors Johnson & Johnson and Merck revealed in previous litigation that both use octocrylene to keep the avobenzone in their sunscreen formulas from degrading, representing two cases of willful patent infringement. L’Oreal is suing the companies in Delaware federal court for injunction and damages.
You may also be interested in...
Merck Faces Consumer Suit Over Coppertone UV Claims
A lawsuit filed in federal court in New Jersey alleges Merck has misrepresented the UV-protective benefits of its Coppertone sunscreen products, subjecting consumers to potential risks.
Merck Faces Consumer Suit Over Coppertone UV Claims
A New Jersey-based suit seeking class action certification alleges Merck has misrepresented the UV-protective benefits of its Coppertone sunscreen products, subjecting consumers to potential risks.
Skinvisible Offers Eight-Hour Photostable Sunscreen Composition
The research and development firm now offers eight-hour photostability in formulas based on its recently patented composition. Skinvisible’s other formulas are avobenzone-based with photostability of around four hours.